These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9285078)

  • 1. Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
    Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO
    Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of lithium in the prophylaxis of affective disorders].
    Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
    Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
    Dardennes R; Lafuma A; Watkins S
    Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
    Juckel G; Mavrogiorgou P; Bredemeier S; Gallinat J; Frodl T; Schulz C; Möller HJ; Hegerl U
    Pharmacopsychiatry; 2004 Mar; 37(2):46-51. PubMed ID: 15048610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it.
    Kallner G; Lindelius R; Petterson U; Stockman O; Tham A
    Pharmacopsychiatry; 2000 Jan; 33(1):8-13. PubMed ID: 10721878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A; Chłopocka-Woźniak M; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who responds to prophylactic lithium therapy?
    Abou-Saleh MT
    Br J Psychiatry Suppl; 1993 Sep; (21):20-6. PubMed ID: 8217063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic lithium treatment on retinal electrophysiologic function.
    Lam RW; Allain S; Sullivan K; Beattie CW; Remick RA; Zis AP
    Biol Psychiatry; 1997 Mar; 41(6):737-42. PubMed ID: 9066998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptophan depletion in recently manic patients treated with lithium.
    Cassidy F; Murry E; Carroll BJ
    Biol Psychiatry; 1998 Feb; 43(3):230-2. PubMed ID: 9494705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of lithium response in bipolar disorder.
    Alda M
    J Psychiatry Neurosci; 1999 Mar; 24(2):154-8. PubMed ID: 10212559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders.
    Pfennig A; Schlattmann P; Alda M; Grof P; Glenn T; Müller-Oerlinghausen B; Suwalska A; Rybakowski J; Willich SN; Bauer M; Berghöfer A
    Bipolar Disord; 2010 Jun; 12(4):390-6. PubMed ID: 20636636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
    Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
    Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium safety in the prophylaxis of bipolar disorders: a study with plasma levels.
    Mauri MC; Laini V; Scalvini ME; Volonteri LS; Ferrari MS; Panza G
    Eur Rev Med Pharmacol Sci; 1999; 3(2):63-9. PubMed ID: 10827806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
    Bowden CL
    J Clin Psychiatry; 1999; 60 Suppl 5():3-4. PubMed ID: 10192401
    [No Abstract]   [Full Text] [Related]  

  • 19. The longitudinal polymorphism of bipolar I disorders and its theoretical implications.
    Marneros A; Roettig S; Roettig D; Tscharntke A; Brieger P
    J Affect Disord; 2008 Apr; 107(1-3):117-26. PubMed ID: 17884177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for physical anhedonia as a candidate symptom or an endophenotype in bipolar affective disorder.
    Etain B; Roy I; Henry C; Rousseva A; Schürhoff F; Leboyer M; Bellivier F
    Bipolar Disord; 2007 Nov; 9(7):706-12. PubMed ID: 17988360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.